In this episode, I break down the latest FDA decision on compounded Tirzepatide and what it really means for patients, providers, and the future of weight loss medications. We’ll talk about the current lawsuits against large compounding pharmacies, the evolving role of other GLP-1s like Liraglutide, and what’s happening behind the scenes with peptides and supplement combos being added to compounds. I also mention upcoming discussions on Sermorelin, NAD+, and why you shouldn’t lose hope if your treatment plan is shifting. Plus, I’m giving you a peek into my personal competition prep—my training, nutrition, travel schedule, and how I’m staying committed through it all. If you’re in the weight loss world, this is one episode you don’t want to miss!